These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33751838)

  • 1. Association of clinical characteristics and lifestyle factors with fecal S100/calgranulin concentrations in healthy dogs.
    Heilmann RM; Guard MM; Toresson L; Unterer S; Grellet A; Grützner N; Suchodolski JS; Steiner JM
    Vet Med Sci; 2021 Jul; 7(4):1131-1143. PubMed ID: 33751838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selected gastrointestinal parasites and viral agents on fecal S100A12 concentrations in puppies as a potential comparative model.
    Heilmann RM; Grellet A; Grützner N; Cranford SM; Suchodolski JS; Chastant-Maillard S; Steiner JM
    Parasit Vectors; 2018 Apr; 11(1):252. PubMed ID: 29665827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy.
    Heilmann RM; Nestler J; Schwarz J; Grützner N; Ambrus A; Seeger J; Suchodolski JS; Steiner JM; Gurtner C
    Vet Immunol Immunopathol; 2019 May; 211():64-74. PubMed ID: 31084897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
    Boschetti G; Garnero P; Moussata D; Cuerq C; Préaudat C; Duclaux-Loras R; Mialon A; Drai J; Flourié B; Nancey S
    Inflamm Bowel Dis; 2015 Feb; 21(2):331-6. PubMed ID: 25625487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.
    Heilmann RM; Berghoff N; Mansell J; Grützner N; Parnell NK; Gurtner C; Suchodolski JS; Steiner JM
    J Vet Intern Med; 2018 Mar; 32(2):679-692. PubMed ID: 29460444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
    Heida A; Van de Vijver E; van Ravenzwaaij D; Van Biervliet S; Hummel TZ; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; van Rheenen PF;
    Arch Dis Child; 2018 Jun; 103(6):565-571. PubMed ID: 29514815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome.
    Thames BE; Barr JW; Suchodolski JS; Steiner JM; Heilmann RM
    J Vet Diagn Invest; 2019 Jul; 31(4):645-651. PubMed ID: 31170888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA; Leach ST; Day AS
    Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal biomarkers in inflammatory bowel disease.
    Lopez RN; Leach ST; Lemberg DA; Duvoisin G; Gearry RB; Day AS
    J Gastroenterol Hepatol; 2017 Mar; 32(3):577-582. PubMed ID: 27723123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical validation of an enzyme-linked immunosorbent assay for the quantification of S100A12 in the serum and feces of cats.
    Bridges CS; Grützner N; Suchodolski JS; Steiner JM; Heilmann RM
    Vet Clin Pathol; 2019 Dec; 48(4):754-761. PubMed ID: 31820477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and analytic validation of an immunoassay for the quantification of canine S100A12 in serum and fecal samples and its biological variability in serum from healthy dogs.
    Heilmann RM; Lanerie DJ; Ruaux CG; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):200-9. PubMed ID: 22030158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference values of fecal calgranulin C (S100A12) in school aged children and adolescents.
    Heida A; Kobold ACM; Wagenmakers L; van de Belt K; van Rheenen PF
    Clin Chem Lab Med; 2017 Nov; 56(1):126-131. PubMed ID: 28708568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study.
    Heida A; Van de Vijver E; Muller Kobold A; van Rheenen P
    BMJ Open; 2017 May; 7(5):e015636. PubMed ID: 28554936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma.
    Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Schlinke A; Alber G; Rösch S; Steiner JM; Seeger J; Oechtering GU; Heilmann RM
    BMC Vet Res; 2022 Nov; 18(1):412. PubMed ID: 36411489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.
    Sipponen T; Haapamäki J; Savilahti E; Alfthan H; Hämäläinen E; Rautiainen H; Koskenpato J; Nuutinen H; Färkkilä M
    Scand J Gastroenterol; 2012 Jul; 47(7):778-84. PubMed ID: 22519419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogs.
    Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Alber G; Kiefer I; Steiner JM; Seeger J; Heilmann RM
    BMC Vet Res; 2023 Nov; 19(1):234. PubMed ID: 37946179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal S100A12 concentration predicts a lack of response to treatment in dogs affected with chronic enteropathy.
    Heilmann RM; Volkmann M; Otoni CC; Grützner N; Kohn B; Jergens AE; Steiner JM
    Vet J; 2016 Sep; 215():96-100. PubMed ID: 27017054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of an enzyme-linked immunosorbent assay (ELISA) for the measurement of canine S100A12.
    Heilmann RM; Cranford SM; Ambrus A; Grützner N; Schellenberg S; Ruaux CG; Suchodolski JS; Steiner JM
    Vet Clin Pathol; 2016 Mar; 45(1):135-47. PubMed ID: 26765807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal and colonic mucosal S100A8/A9 (calprotectin) expression is increased and correlates with the severity of select histologic lesions in dogs with chronic inflammatory enteropathy.
    Nestler J; Syrjä P; Kilpinen S; Moniz CA; Spillmann T; Hanifeh M; Heilmann RM
    BMC Vet Res; 2024 Sep; 20(1):393. PubMed ID: 39238011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.